The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, or analogous product, or any therapeutic serum used for the treatment of a disease in humans. These biological products were developed from multicellular systems comprising of plants, animals, unicellular organisms and a mammalian cell. Biological products are composed of sugars, nucleic acids or combination of both.
The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.
Market Analysis and Insights: Global Biological Product Manufacturing Market
The global Biological Product Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biological Product Manufacturing Scope and Market Size
Biological Product Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biological Product Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Biological Product Manufacturing Breakdown Data by Type
Monoclonal Antibodies
Recombinant Proteins
Growth Hormones
Beta Interferon
Therapeutic Enzymes
Biological Product Manufacturing Breakdown Data by Application
Hospitals
Specialized Clinics
Government Research Institutes
The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.
Market Analysis and Insights: Global Biological Product Manufacturing Market
The global Biological Product Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biological Product Manufacturing Scope and Market Size
Biological Product Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biological Product Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Biological Product Manufacturing Breakdown Data by Type
Monoclonal Antibodies
Recombinant Proteins
Growth Hormones
Beta Interferon
Therapeutic Enzymes
Biological Product Manufacturing Breakdown Data by Application
Hospitals
Specialized Clinics
Government Research Institutes
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biological Product Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Biological Product Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Growth Hormones
1.4.5 Beta Interferon
1.4.6 Therapeutic Enzymes
1.5 Market by Application
1.5.1 Global Biological Product Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Government Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biological Product Manufacturing Market Perspective (2015-2026)
2.2 Global Biological Product Manufacturing Growth Trends by Regions
2.2.1 Biological Product Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biological Product Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Biological Product Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biological Product Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Biological Product Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biological Product Manufacturing Players by Market Size
3.1.1 Global Top Biological Product Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Biological Product Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Biological Product Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biological Product Manufacturing Market Concentration Ratio
3.2.1 Global Biological Product Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biological Product Manufacturing Revenue in 2019
3.3 Biological Product Manufacturing Key Players Head office and Area Served
3.4 Key Players Biological Product Manufacturing Product Solution and Service
3.5 Date of Enter into Biological Product Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biological Product Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Biological Product Manufacturing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biological Product Manufacturing Market Size by Application (2015-2020)
5.2 Global Biological Product Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biological Product Manufacturing Market Size (2015-2020)
6.2 Biological Product Manufacturing Key Players in North America (2019-2020)
6.3 North America Biological Product Manufacturing Market Size by Type (2015-2020)
6.4 North America Biological Product Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biological Product Manufacturing Market Size (2015-2020)
7.2 Biological Product Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Biological Product Manufacturing Market Size by Type (2015-2020)
7.4 Europe Biological Product Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Biological Product Manufacturing Market Size (2015-2020)
8.2 Biological Product Manufacturing Key Players in China (2019-2020)
8.3 China Biological Product Manufacturing Market Size by Type (2015-2020)
8.4 China Biological Product Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biological Product Manufacturing Market Size (2015-2020)
9.2 Biological Product Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Biological Product Manufacturing Market Size by Type (2015-2020)
9.4 Japan Biological Product Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biological Product Manufacturing Market Size (2015-2020)
10.2 Biological Product Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biological Product Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Biological Product Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Biological Product Manufacturing Market Size (2015-2020)
11.2 Biological Product Manufacturing Key Players in India (2019-2020)
11.3 India Biological Product Manufacturing Market Size by Type (2015-2020)
11.4 India Biological Product Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biological Product Manufacturing Market Size (2015-2020)
12.2 Biological Product Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Biological Product Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Biological Product Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Biological Product Manufacturing Introduction
13.1.4 Novartis Revenue in Biological Product Manufacturing Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Details
13.2.2 F.Hoffmann-La Roche Business Overview
13.2.3 F.Hoffmann-La Roche Biological Product Manufacturing Introduction
13.2.4 F.Hoffmann-La Roche Revenue in Biological Product Manufacturing Business (2015-2020)
13.2.5 F.Hoffmann-La Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Biological Product Manufacturing Introduction
13.3.4 Merck Revenue in Biological Product Manufacturing Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer Biological Product Manufacturing Introduction
13.4.4 Bayer Revenue in Biological Product Manufacturing Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Lonza
13.5.1 Lonza Company Details
13.5.2 Lonza Business Overview
13.5.3 Lonza Biological Product Manufacturing Introduction
13.5.4 Lonza Revenue in Biological Product Manufacturing Business (2015-2020)
13.5.5 Lonza Recent Development
13.6 China Biologic Products
13.6.1 China Biologic Products Company Details
13.6.2 China Biologic Products Business Overview
13.6.3 China Biologic Products Biological Product Manufacturing Introduction
13.6.4 China Biologic Products Revenue in Biological Product Manufacturing Business (2015-2020)
13.6.5 China Biologic Products Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Biological Product Manufacturing Introduction
13.7.4 Pfizer Revenue in Biological Product Manufacturing Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview
13.8.3 Sanofi Biological Product Manufacturing Introduction
13.8.4 Sanofi Revenue in Biological Product Manufacturing Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Biological Product Manufacturing Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Biological Product Manufacturing Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Amgen
13.10.1 Amgen Company Details
13.10.2 Amgen Business Overview
13.10.3 Amgen Biological Product Manufacturing Introduction
13.10.4 Amgen Revenue in Biological Product Manufacturing Business (2015-2020)
13.10.5 Amgen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biological Product Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Biological Product Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Growth Hormones
1.4.5 Beta Interferon
1.4.6 Therapeutic Enzymes
1.5 Market by Application
1.5.1 Global Biological Product Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Government Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biological Product Manufacturing Market Perspective (2015-2026)
2.2 Global Biological Product Manufacturing Growth Trends by Regions
2.2.1 Biological Product Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biological Product Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Biological Product Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biological Product Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Biological Product Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biological Product Manufacturing Players by Market Size
3.1.1 Global Top Biological Product Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Biological Product Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Biological Product Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biological Product Manufacturing Market Concentration Ratio
3.2.1 Global Biological Product Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biological Product Manufacturing Revenue in 2019
3.3 Biological Product Manufacturing Key Players Head office and Area Served
3.4 Key Players Biological Product Manufacturing Product Solution and Service
3.5 Date of Enter into Biological Product Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biological Product Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Biological Product Manufacturing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biological Product Manufacturing Market Size by Application (2015-2020)
5.2 Global Biological Product Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biological Product Manufacturing Market Size (2015-2020)
6.2 Biological Product Manufacturing Key Players in North America (2019-2020)
6.3 North America Biological Product Manufacturing Market Size by Type (2015-2020)
6.4 North America Biological Product Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biological Product Manufacturing Market Size (2015-2020)
7.2 Biological Product Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Biological Product Manufacturing Market Size by Type (2015-2020)
7.4 Europe Biological Product Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Biological Product Manufacturing Market Size (2015-2020)
8.2 Biological Product Manufacturing Key Players in China (2019-2020)
8.3 China Biological Product Manufacturing Market Size by Type (2015-2020)
8.4 China Biological Product Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biological Product Manufacturing Market Size (2015-2020)
9.2 Biological Product Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Biological Product Manufacturing Market Size by Type (2015-2020)
9.4 Japan Biological Product Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biological Product Manufacturing Market Size (2015-2020)
10.2 Biological Product Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biological Product Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Biological Product Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Biological Product Manufacturing Market Size (2015-2020)
11.2 Biological Product Manufacturing Key Players in India (2019-2020)
11.3 India Biological Product Manufacturing Market Size by Type (2015-2020)
11.4 India Biological Product Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biological Product Manufacturing Market Size (2015-2020)
12.2 Biological Product Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Biological Product Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Biological Product Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Biological Product Manufacturing Introduction
13.1.4 Novartis Revenue in Biological Product Manufacturing Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Details
13.2.2 F.Hoffmann-La Roche Business Overview
13.2.3 F.Hoffmann-La Roche Biological Product Manufacturing Introduction
13.2.4 F.Hoffmann-La Roche Revenue in Biological Product Manufacturing Business (2015-2020)
13.2.5 F.Hoffmann-La Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Biological Product Manufacturing Introduction
13.3.4 Merck Revenue in Biological Product Manufacturing Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer Biological Product Manufacturing Introduction
13.4.4 Bayer Revenue in Biological Product Manufacturing Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Lonza
13.5.1 Lonza Company Details
13.5.2 Lonza Business Overview
13.5.3 Lonza Biological Product Manufacturing Introduction
13.5.4 Lonza Revenue in Biological Product Manufacturing Business (2015-2020)
13.5.5 Lonza Recent Development
13.6 China Biologic Products
13.6.1 China Biologic Products Company Details
13.6.2 China Biologic Products Business Overview
13.6.3 China Biologic Products Biological Product Manufacturing Introduction
13.6.4 China Biologic Products Revenue in Biological Product Manufacturing Business (2015-2020)
13.6.5 China Biologic Products Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Biological Product Manufacturing Introduction
13.7.4 Pfizer Revenue in Biological Product Manufacturing Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview
13.8.3 Sanofi Biological Product Manufacturing Introduction
13.8.4 Sanofi Revenue in Biological Product Manufacturing Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Biological Product Manufacturing Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Biological Product Manufacturing Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Amgen
13.10.1 Amgen Company Details
13.10.2 Amgen Business Overview
13.10.3 Amgen Biological Product Manufacturing Introduction
13.10.4 Amgen Revenue in Biological Product Manufacturing Business (2015-2020)
13.10.5 Amgen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
